“More Than a Ticket. It’s Your Seat at the Table.”
Join a private forum where purpose meets progress. At GBX, expect powerful conversations, trusted connections and the space to shape what’s next. No distractions - just the people, ideas and momentum that move industries forward.
PAST SPEAKERS
Judy Chou
President and CEO of AltruBio
Uwe Gottschalk
Operating Partner at Keensight Capital
Nuno Fontes
SVP, Head of Global CMC at WuXi Biologics
For the patients, we must do better.
18th Annual Bio Innovation Leaders Summit 2026
11th & 12th February 2026
London (exact location TBC)
Co-Located 4th Annual Meat Evolution Leaders Summit #MEVO
The Private Forum for Biomanufacturing Leaders Who Refuse to Wait for the Future
BILS 2026 is closed-door forum for those entrusted with one of the most complex challenges in life sciences: reimagining how we manufacture biology - at speed, at scale and with global purpose.
This gathering is purpose-built for global decision-makers in biologics, bioprocessing, digital manufacturing, CMC and strategic partnerships. It’s where scientific vision and operational reality meet - and where real systems are shaped, refined and redefined.
Whether you're overseeing global biologics capacity, navigating tech transfer, scaling a next-gen therapeutic, integrating smart factory systems or leading platform innovation, this is where you step forward.
Not to attend - but to lead, connect and act.
CURRENT SPEAKERS
SUMMIT INSIGHTS
Who Attends
-
Global VP, Biologics Manufacturing
-
VP, Process Development & MSAT
-
VP, Digital Manufacturing & Automation
-
VP, CMC & Technical Development
-
VP, Quality & Regulatory Affairs - Bioproduction
-
VP, External Manufacturing & Strategic Partnerships
-
COO - CSO - Head of Biomanufacturing Strategy
-
Designing intelligent, responsive manufacturing systems
-
Transitioning from batch to continuous and modular infrastructure
-
Scaling platforms for mRNA, CGT and novel biologics
-
Tech transfer transformation and CMC acceleration
-
Digital twins, AI and automation in bioproduction
-
Quality-by-design and global GMP readiness
-
Sustainability as infrastructure, not initiative
Two Industries. One Biosphere. Unlimited Collaboration.
MEVO 2026, the leading forum for cultivated meat and precision fermentation.
-
This unique convergence creates powerful opportunities:
-
Shared technologies (bioreactors, single-use systems, downstream purification)
-
Cross-sector insights into scale-up, validation and regulatory fluency
-
Direct access to new partnership pathways between pharma, food and synthetic biology
Joshi Venugopal
GM & Head of Europe
Novartis Gene Therapies & Rare Diseases
Dorothee Ambrosius
Former Head of CMC Strategy Biologicals
Boehringer Ingelheim
Warner Biddle
Former Global Head of Commercial
Kite, a Gilead Company
Gwendolyn Binder
President of Science & Technology
Cabaletta Bio
Pierre Caloz
COO
uniQure
Paolo Martini
Former CSO
Moderna
IN PERSON ONLY
Unmatched peer exchange with up to 200 qualified executives tackling shared challenges in speed, quality and sustainability
SUMMIT
INSIGHTS
Our Mission
Our purpose is to create a gathering that empowers and inspires critical decision-making; sparking new opportunities to amplify their impact within the biologics and cell and gene therapy value chain.
We encourage collaboration and innovation, which is why this summit ensures that each participant contributes significantly to advancing the field. It serves as a platform for sharing insights, fostering partnerships and driving forward the next wave of breakthroughs in biologics.
For the patients, we must do better.
Investors and large biopharma companies need to satisfy environmental compliance. We will keynote the progression toward more sustainable bioprocesses, manufacturing and supply methods, amalgamating toward building a sustainable and digitised ecosystem - an emerging frontier of digitisation and industry 4.0.
Closing session by Merck.
Attendee Profile
C-Suite - Directors - Executives
Bioprocess - Manufacturing - IT-Data Integration - Commercial and Business Development - Scientists - Supply Chain - Production - PAT
Focus Area
CGT
Antibody Drugs
Vaccine
Small molecule, conjugates and peptides
Technology or Service Companies
CRO
CDMO
Biologic workflow solutions
Advance Bioprocessing
End to end workflow solutions
Digitising - AI - Data
Automation - Robotics
Filtration - Single use - Bioreactors
Event highlights
Pre Event Innovation Tour - Private Innovation Tour - CXO
Please click to Tour 2024
Evening of day one -Private Networking Dinner
Journey of a CXO
Exclusive closed-door talks from some of the most prominent leaders in the industry who will be talking about their journey, lessons learnt and vision for the future.
Attendance Guide
30% Asian Biopharma
25% International Biopharma
20% CMOs - CDMOS's
15% Academic & Research Institutes
10% Technology & Service Providers
Curated Meetings
Packages have sold out
Guaranteed pre-qualified strategy meetings
Prior contact
Mutual benefit
Conducted by our specialists
Geography
25% Korea & Japan
20% Singapore
20% Indonesia, Thailand, Philippines, Malaysia, India & Australia
15% China, Hong Kong & Taiwan
15% USA
5% UAE
PREVIOUS SPEAKERS
This is where the scientific promise of novel therapies meets the operational reality of delivering them - safely, efficiently and globally.
ADVISORY
Join BILS 2026 to shape the next decade of biologics manufacturing
Subscribe to Our Mailing List
